Meet with BIOVECTRA at DCAT Week 2024!

Event Details


New York City | March 18-21, 2024

BIOVECTRA is a North American CDMO specializing in the clinical-to-commercial scale production of high-quality regulated APIs and intermediates, including:

  • Biologics
  • Synthetic small molecules
  • pDNA and mRNA
  • Highly potent APIs
  • Bioreagents
  • Fill/Finish

Our team – backed by 50+ years of experience – looks forward to the opportunity to put our flexible, innovative manufacturing solutions at your disposal.